Parexel FSPs, Lisa Feeney, Vice President, FSP Operations, is joined by Jennifer Sheller, North America Regional Head, Global Clinical Trial Operations at Merck, to discuss how to prepare the CRA
Watch Video
In this whitepaper, we address the unique variables, optimal timing, and immunogenic considerations for vaccinating individuals with cancer.
Read Flipbook
Read Article
Read Flipbook
This article shares Parexel’s view of change drivers, essential infrastructure components, and advancing FSP capabilities over the next five years.
Read Flipbook
Parexel regulatory expert, Mark Birse, gives an update on BREXIT.
Watch Video
Biotech companies are the driving force behind the industry’s R&D pipeline as they develop and launch increasingly complex treatments. With more than 80% of the assets in development managed by...
Read More
In this research report, get critical insights into why families join clinical trials and how to design patient-centric trials to better fit their needs.
Read Flipbook
Learn more about how Parexel is approaching the challenges of conducting rare disease clinical trials.
Read Flipbook
Learn more about the benefits of Decentralized Clinical Trials including home healthcare support, telemedicine and sensors, direct-to-patient drug shipments, and more.
Read Flipbook
In this PharmaTalk episode, get guidance from patient innovation and technology experts about harnessing technology in order to deploy Decentralized Clinical Trials and improve patient care.
Read Article
Within this eBook, Parexel subject matter experts speak to some of the exciting trends that are moving the industry toward the drug development of the future.
Read Flipbook
Read Article
Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.
Read Flipbook
Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.
Read Flipbook
Recommendations for navigating the "new normal" and how to prepare for the future.
Read Article
Paul Bridges on the EU Clinical Trial Regulation (CTR)
Watch Video
Learn how to improve identification, recruitment and retention of rare disease patients.
Read Flipbook
Read Flipbook
Read Article
Loading More...
